In preclinical studies, TGF-β signalling was found to modulate E-cadherin, vimentin, and integrin expression in HCC cells, implying a role in triggering the epithelial-mesenchymal transition (EMT) [9–13]. Here, TGFB1 is linked to hepatocellular carcinoma.